Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wisniewski

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Neurologic Clinics|October 11, 2016
Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for TherapeuticsRichard A Hickman, Arline Faustin, Thomas Wisniewski
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|September 18, 2008
Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutationSteven P Cercy, Martin J Sadowski, Thomas Wisniewski
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Use of Affinity Purification-Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer's DiseaseGeoffrey Pires, Beatrix Ueberheide, Thomas Wisniewski, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2025
Reducing ARIA risk in Alzheimer's disease: Real-world impact of <i>APOE</i> genotype-guided slow titration with aducanumab and lecanemabNicholas Mervosh, Nadir Bilici, Thomas Wisniewski, et al.
Journal of Neuroimmunology|June 23, 2026
Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655]Richard Rubenstein, Allen Chiu, Binggong Chang, et al.
Journal of Neuroimmunology|February 20, 2013
Role of CD40 in prion disease and the immune response to recombinant PrPRichard Rubenstein, Allen Chiu, Binggong Chang, et al.
Current Alzheimer Research|October 11, 2016
Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's DiseaseAllal Boutajangout, Abdulwahab Noorwali, Hazem Atta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2023
Vigorous, regular physical exercise may slow disease progression in Alzheimer's diseaseDavangere P Devanand, Arjun V Masurkar, Thomas Wisniewski
Current Neurology and Neuroscience Reports|July 16, 2020
Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging BrainRichard A Hickman, Xena E Flowers, Thomas Wisniewski
Plos One|November 3, 2011
Dissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against β3 integrinSuying Dang, Tao Hong, Thomas Wisniewski, et al.
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Neurologic Clinics|October 11, 2016
Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for TherapeuticsRichard A Hickman, Arline Faustin, Thomas Wisniewski
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|September 18, 2008
Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutationSteven P Cercy, Martin J Sadowski, Thomas Wisniewski
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Use of Affinity Purification-Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer's DiseaseGeoffrey Pires, Beatrix Ueberheide, Thomas Wisniewski, et al.
Journal of Alzheimer'S Disease : JAD|August 13, 2025
Reducing ARIA risk in Alzheimer's disease: Real-world impact of <i>APOE</i> genotype-guided slow titration with aducanumab and lecanemabNicholas Mervosh, Nadir Bilici, Thomas Wisniewski, et al.
Journal of Neuroimmunology|June 23, 2026
Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655]Richard Rubenstein, Allen Chiu, Binggong Chang, et al.
Journal of Neuroimmunology|February 20, 2013
Role of CD40 in prion disease and the immune response to recombinant PrPRichard Rubenstein, Allen Chiu, Binggong Chang, et al.
Current Alzheimer Research|October 11, 2016
Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's DiseaseAllal Boutajangout, Abdulwahab Noorwali, Hazem Atta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2023
Vigorous, regular physical exercise may slow disease progression in Alzheimer's diseaseDavangere P Devanand, Arjun V Masurkar, Thomas Wisniewski
Current Neurology and Neuroscience Reports|July 16, 2020
Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging BrainRichard A Hickman, Xena E Flowers, Thomas Wisniewski
Plos One|November 3, 2011
Dissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against β3 integrinSuying Dang, Tao Hong, Thomas Wisniewski, et al.
Pageof 32